共 48 条
- [1] Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study) [J]. ADVANCES IN THERAPY, 2022, 39 (05) : 2109 - 2127
- [2] Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-Up Results From an Observational Real World Study Among Patients With Inflammatory Bowel Disease (ONWARD Study) [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S364 - +